Louis J. Kang

Louis J. Kang has been involved in a variety of professional roles since 2010. In that year, they began working on various projects attempting to address global challenges as a Doer/Thinker. In 2019, they became a Venture Partner at KTB Ventures. In 2020, they became a Co-Founder at March Therapeutics, Inc. and a Partner at ACCELR8. Most recently, in 2022, they became a Member of the Leadership Board at Beth Israel Deaconess Medical Center.

Louis J. Kang received their Doctor of Philosophy (Ph.D.) in Applied Physics from Harvard University, a Bachelor of Science (B.S.) in Electrical Engineering and Computer Sciences & Materials Science and Engineering from the University of California, Berkeley, and studied Multi/Interdisciplinary Studies at the Massachusetts Institute of Technology.